If you would like to inquire about all open trials, please contact 919.684.3401.
1 trial identified.
An Open Label, Expanded Access Protocol Using (131)I-Metaiodobenzylguanidine (I-MIBG) Therapy in Patients with Refractory Neuroblastoma Phase: Other Sponsor: OTHER Principal Investigator: Jessica Sun Contact: Dr. Michael Armstrong Phone: 919.684.3401 Reference Number: 00012332 View this trial at ClinicalTrials.gov
Ways To Give
Duke Cancer Institute constellates the world-class resources of Duke University, Duke Health and the Duke Comprehensive Cancer Center into a collaborative powerhouse. We are poised to drive a paradigm shift in the way long-established cancer centers and institutes have been waging this war.